Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIBW 2948 BS in COPD and Chronic Bronchitis
NCT00423137Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of BIBW 2948 BS in chronic obstructive pulmonary disease (COPD), chronic bronchitis (CB), sponsored by Boehringer Ingelheim. Started Jan 2007; status: completed.
02
Drugs
BIBW 2948 BS
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00423137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423137.